Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From I-Hub (Nerverending)

Are you really trying to justify a $3 share price? Even the $0.25/share rev number is an optimistic scenario.

The cognitive dissonance that goes on here is amazing. Even as PTSC sits at $0.11, is embroiled in litigation that threatens it's core business, and hasn't produced new license revenue for what, a couple of quarters? Even with all that everyone is coming up with the "early mover" rhetoric, "hundreds on notice" and the same old crap. Justifying $3.00 share prices. It's hard to believe.

Share
New Message
Please login to post a reply